Literature DB >> 18803355

Is there a role for Tc-99m (V) DMSA scintigraphy in ischemic colitis?

Maria I Stathaki1, Ioannis E Koutroubakis, Sophia I Koukouraki, Elias A Kouroumalis, Nikolaos S Karkavitsas.   

Abstract

AIM: To evaluate the role of pentavalent Tc-99m dimercaptosuccinic acid [Tc-99m (V) DMSA] in the diagnosis of ischemic colitis.
METHODS: Fourteen patients with endoscopically and histologically confirmed ischemic colitis were included in the study. Tc-99m (V) DMSA scintigraphy was performed within 2 d after colonoscopy. Images were considered positive when an area of increased activity was observed in the region of interest and negative when no abnormal tracer uptake was detected.
RESULTS: In 3 out of the 14 patients, Tc-99m (V) DMSA images showed moderate activity in the bowel. The scintigraphic results corresponded with the endoscopic findings. In the other 11 patients, no abnormal tracer uptake was detected in the abdomen.
CONCLUSION: Besides the limited number of patients, Tc-99m (V) DMSA could not be considered as a useful imaging modality for the evaluation of ischemic colitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803355      PMCID: PMC2744169          DOI: 10.3748/wjg.14.5432

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

Review 1.  Diagnosis and management of intestinal ischaemic disorders.

Authors:  Jayaprakash Sreenarasimhaiah
Journal:  BMJ       Date:  2003-06-21

2.  Indium-111 neutrophil imaging in ischemic colitis.

Authors:  D Bell; M Jackson; J J Connaughton
Journal:  J Nucl Med       Date:  1986-11       Impact factor: 10.057

Review 3.  Ischaemic colitis: two distinct patterns of severity.

Authors:  J H Robert; G Mentha; A Rohner
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

Review 4.  Preoperative prediction of extent and severity of ischemic colitis by imaging with in-111 labeled leukocytes.

Authors:  V Vijayakumar; C Bekerman; M J Blend
Journal:  Clin Nucl Med       Date:  1991-02       Impact factor: 7.794

Review 5.  Ischaemic colitis.

Authors:  P H MacDonald
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-02       Impact factor: 3.043

6.  Investigation and management of ischemic colitis.

Authors:  Jorge Baixauli; Ravi P Kiran; Conor P Delaney
Journal:  Cleve Clin J Med       Date:  2003-11       Impact factor: 2.321

7.  Low plasma protein Z levels in patients with ischemic colitis.

Authors:  Ioannis E Koutroubakis; Angeliki Theodoropoulou; Aekaterini Sfiridaki; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

8.  Ischemic colitis: spectrum of disease and outcome.

Authors:  James R Scharff; Walter E Longo; Shant M Vartanian; Donald L Jacobs; Anil N Bahadursingh; Donald L Kaminski
Journal:  Surgery       Date:  2003-10       Impact factor: 3.982

9.  Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy.

Authors:  Ioannis E Koutroubakis; Sophia I Koukouraki; Philippos D Dimoulios; Antigoni A Velidaki; Nikolaos S Karkavitsas; Elias A Kouroumalis
Journal:  Radiology       Date:  2003-08-18       Impact factor: 11.105

10.  Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy.

Authors:  Maria I Stathaki; Ioannis E Koutroubakis; Sophia I Koukouraki; Konstantinos P Karmiris; Joanna A Moschandreas; Elias A Kouroumalis; Nikolaos S Karkavitsas
Journal:  Nucl Med Commun       Date:  2008-01       Impact factor: 1.690

View more
  2 in total

Review 1.  Ischemic colitis.

Authors:  James F FitzGerald; Luis O Hernandez Iii
Journal:  Clin Colon Rectal Surg       Date:  2015-06

Review 2.  Ischemic colitis: clinical practice in diagnosis and treatment.

Authors:  Angeliki Theodoropoulou; Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.